Citius Pharmaceuticals Inc. (CTXR) stock declined during current market trading. Let’s see what’s happening
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) stock fell by 12.50% in the current trading session. Citius is a late-stage biopharmaceutical business focused on developing and commercializing first-in-class critical care medicines, with a focus on anti-infectives as adjuvant cancer therapy, unique prescription medications, and stem cell therapy. >> 7 Top Picks for the Post-Pandemic Economy << What […]